Microsoft stock rebounds toward key resistance as Copilot AI deal boosts sentiment

Microsoft stock rebounds toward key resistance as Copilot AI deal boosts sentiment
Microsoft shares extend recovery toward $530 as new AI partnerships revive bullish sentiment

​Microsoft (NASDAQ: MSFT) is trading around $524, extending its recovery from September lows and regaining key technical footing above major moving averages. The rebound from the $492 base has reestablished bullish momentum, supported by renewed investor optimism surrounding the company’s latest AI expansion. 

Highlights

- Microsoft rebounds from September lows, reclaiming key EMAs and targeting the $530 resistance zone.

- Copilot AI expands into healthcare through Harvard Medical School deal, reducing reliance on OpenAI.

- A breakout above $530 could trigger an extension toward $541–$555, maintaining a bullish medium-term trend.

The daily chart shows Microsoft breaking out of its recent corrective channel and reclaiming the 20-day EMA at $515.7, with price now testing the 0.618 Fibonacci retracement level at $530. A decisive close above this zone could open the door toward the $555 high reached in late summer.

Technical momentum strengthens after September correction

Microsoft’s technical backdrop has shifted firmly in favor of the bulls. The 50-day EMA at $509 and the 100-day EMA at $493 continue to act as strong support, while the 200-day EMA sits comfortably below at $467, underscoring the long-term uptrend. Momentum indicators show steady improvement, with the RSI climbing from oversold territory to around 54, suggesting that buying interest is building again.

MSFT price dynamics (Source: TradingView)

A breakout above $530 would likely confirm the continuation of the recovery phase, paving the way toward the 0.786 Fibonacci resistance near $541 and, ultimately, a retest of $555. On the downside, immediate support rests around the $515–$509 cluster, followed by the $492 pivot that defined September’s bottom. As long as the price remains above these levels, the medium-term trend remains constructive.

AI expansion fuels investor optimism

Beyond the charts, Microsoft’s fundamentals are getting a boost from its deepening push into artificial intelligence. Harvard Medical School’s new licensing deal with Microsoft grants the company access to extensive consumer health content, broadening the reach of its Copilot AI assistant beyond workplace productivity tools. The agreement is seen as a key step in reducing Microsoft’s dependence on OpenAI and strengthening its proprietary AI capabilities.

The move also aligns with the company’s strategy of embedding AI across its software ecosystem—from Windows to Azure—and expanding into specialized verticals such as healthcare. Analysts view these efforts as pivotal to maintaining Microsoft’s competitive advantage in the fast-evolving AI landscape, with potential for new revenue streams through integration of health data into Copilot’s knowledge model.

Outlook

Microsoft’s short-term trajectory hinges on its ability to break through the $530 resistance barrier. Clearing this level could confirm a shift from consolidation to continuation, while a failure would likely trigger a brief pullback toward $515 or $509 before another attempt higher. With strong technical support and ongoing strategic momentum in AI, the broader trend remains favorable.

Earlier analysis identified $492 as the critical base that could anchor a rebound. That level has since held, validating the view that Microsoft’s long-term channel remains intact as the company continues to strengthen its position in the AI sector.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.